Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells
Open Access
- 27 April 2000
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 86 (5) , 617-625
- https://doi.org/10.1002/(sici)1097-0215(20000601)86:5<617::aid-ijc3>3.0.co;2-z
Abstract
The ErbB receptor tyrosine kinase family consists of the epidermal growth factor (EGF) receptor (ErbB1) and three related receptors (ErbB2, ErbB3, ErbB4). Their intrinsic tyrosine kinases can be activated by receptor‐dimerization induced by numerous ligands or overexpression. ErbB receptors are frequently overexpressed in breast cancer, and their overexpression is associated with protection from apoptosis. To directly assess their role in apoptosis sensitivity of breast cancer cells, we established MCF‐7 breast carcinoma cell lines overexpressing each ErbB receptor alone or in all possible pairs. Overexpression of ErbB1, ErbB2 and ErbB4 receptors was enough to activate them as judged by their phosphorylation, whereas co‐expression of other ErbB receptors was necessary for the phosphorylation of the ErbB3. Surprisingly, overexpression of the ErbB receptors even when combined with treatment with their ligands (EGF, transforming growth factor α, betacellulin, neuregulins) failed to protect the MCF‐7 cells from cell death induced by either tumor necrosis factor (TNF) or serum starvation. During starvation TGF‐α, however, increased the cell size of the ErbB1 overexpressing cell line, and neuregulin1‐β1 increased that of all cell lines. In conclusion, our data does not support the role of ErbB receptors in the regulation of cell death induced by TNF or serum starvation, and the observed association in breast cancer may be due to other concomitant changes. Int. J. Cancer 86:617–625, 2000.Keywords
This publication has 33 references indexed in Scilit:
- Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinaseOncogene, 1999
- Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-αCancer Immunology, Immunotherapy, 1998
- Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cellsCancer Immunology, Immunotherapy, 1996
- C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicatorsBritish Journal of Cancer, 1996
- Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat schwann cell precursorsNeuron, 1995
- Heregulin Activation of Extracellular Acidification in Mammary Carcinoma Cells Is Associated with Expression of HER2 and HER3Published by Elsevier ,1995
- Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptorMolecular and Cellular Endocrinology, 1995
- Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer researchBreast Cancer Research and Treatment, 1995
- Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.Proceedings of the National Academy of Sciences, 1994
- Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1988